Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' p... Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.55 | -1.72684458399 | 31.85 | 32.88 | 30.64 | 621978 | 31.64499643 | CS |
| 4 | -3.02 | -8.79953379953 | 34.32 | 36.15 | 30.64 | 702611 | 33.29667163 | CS |
| 12 | -2.9 | -8.47953216374 | 34.2 | 36.15 | 30.64 | 725941 | 33.50585356 | CS |
| 26 | -15.55 | -33.1910352188 | 46.85 | 62.58 | 30.64 | 761627 | 41.16246928 | CS |
| 52 | 1.03 | 3.40270895276 | 30.27 | 62.58 | 27.14 | 694132 | 40.48076166 | CS |
| 156 | 1.9 | 6.46258503401 | 29.4 | 62.58 | 16.75 | 624948 | 31.06454349 | CS |
| 260 | -2 | -6.00600600601 | 33.3 | 62.58 | 16.75 | 643939 | 36.64531701 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
